Skip to main content
. 2018 Nov 21;27(4):1303–1318. doi: 10.1044/2018_AJSLP-17-0227

Table 4.

Neurologic data for all patients for each visit.

Patient ID Visit number MoCA (/30) FAB (/18) FBI (/72) UPDRS III (/120) NPI-Q (/36) NVOA (/32) Additional symptoms
1 1 27 18 12 5 5 14 Pseudobulbar affect
1 2 27 16 6 16 4 0 Mild Parkinsonism
1 3 25 16 6 13 2 3
1 4 23 14 7 41 4 0 Facial dystonia
1 5 21 8 16 49 5 0 CBS
1 6 12 DNT DNT 69 DNT 0 Myoclonus/mod. Parkinsonism
2 1 28 17 3 6 1 32
2 2 21 15 1 13 0 31 Mild Parkinsonism
2 3 25 15 8 21 0 20 Yes/no reversal
2 4 27 15 2 34 2 21
2 5 24 15 5 34 2 6 Depression
2 6 23 1 13 61 0 0 Mod. Parkinsonism
3 1 25 17 3 15 0 31 Postural tremor
3 2 27 15 3 24 0 30 Yes/no reversal
3 3 29 16 9 32 1 20 Mild Parkinsonism
3 4 24 13 20 30 2 19 Mild rigidity
3 5 26 14 13 55 1 11 Mod. Parkinsonism
3 6 24 12 28 58 6 2
4 1 27 18 2 8 0 32
4 2 26 17 4 6 2 32 Pronoun reversal
4 3 25 16 14 6 2 26 Hearing loss
4 4 21 17 17 7 6 8 Stereotype (“ok”)/depression
4 5 21 14 26 15 6 1

Note. Maximum score noted in each column header. MoCA = Montréal Cognitive Assessment; FAB = Frontal Assessment Battery; FBI = Frontal Behavioural Inventory; UPDRS III = the Movement Disorders Society-sponsored version of the Unified Parkinson's Disease Rating Scale motor subsection; NPI-Q = Neuropsychiatric Inventory Questionnaire; NVOA = nonverbal oral apraxia; CBS = corticobasal syndrome; Mod. = moderate; DNT = did not test.